At a glance
ClinicalIndex Comparison RecordN/ACompleted· 8 enrolled
Drug / intervention
Tattoo machinedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
In Brief
A clinical study evaluating Tattoo machine for Androgenic Alopecia. Completed, enrolled 8 participants across 1 site.
Detailed Summary
The intent of this study is to evaluate the efficacy of microneedling through use of a professional tattoo machine in hair regrowth in patients with androgenic alopecia (AGA) over up to 6 treatments (6 months).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAndrogenic Alopecia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartApr 2021
Primary CompletionMay 2022
TodayJul 2026
First PostedApr 10, 2020
Enrollment StartApr 9, 2021
Primary CompletionMay 2, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.2 years ago
Interventions
Tattoo machinedevice
A SOL Nova Device (brand) tattoo machine will be used to stimulate hair regrowth.